AACR: TTFields + Temozolomide Ups Survival in Glioblastoma

Compliance with TTFields treatment predicts outcome, with better outcome for>18 hour/day
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Neurology, Oncology, Conference News, Source Type: news